Brian Winbigler

Provider Working Group Lead

Dr. Brian Winbigler leads the Provider Working Group. In this role he works with county healthcare professionals to offer development opportunities, including but not limited to education on the science of addiction, addiction as a chronic disease, SBIRT, MAT, CPT and ICD10 coding, and connections to resources.

Dr. Brian Winbigler, a native of Blount County, received a Bachelor of Science degree in biochemistry and cellular and molecular biology from The University of Tennessee Knoxville, a Master of Business Administration from Lincoln Memorial University, a Doctor of Pharmacy degree (PharmD) from the University of TN Health Science Center, and completed a community pharmacy residency. As an Assistant Professor in the department of clinical pharmacy and translational science at the University Of Tennessee College Of Pharmacy, Dr. Winbigler directs the Substance Use Disorders elective and related content in other modules.  He also works with the TN Department of Mental Health and Substance Abuse Services as a Regional Overdose Prevention Specialist, providing training and education on opioid overdose and for overdose prevention through the distribution of naloxone.  In the community he volunteers and serves as chair for Blount County’s Substance Abuse and Prevention Action Team, educator for Harbours Gate, and works with the Knox County Harm Reduction Coalition.  All three organizations provide educational opportunities and resources that address substance misuse prevention and treatment. He serves on the Blount County Board of Health, board of Harbours Gate, and the UT Alumni Association Board of Governors.  He holds active membership in both state and national organizations including the American Pharmacist Association, American Association of Colleges of Pharmacy, and Tennessee Pharmacist Association (TPA) serving on the TPA Resolutions Committee and secretary for TPA-Tennessee Society of Chain Pharmacists.  Dr. Winbigler is the recipient of both State and Federal funds for opioid related research.